457 related articles for article (PubMed ID: 6145881)
1. Seroepidemiological studies of human T-lymphotropic retrovirus type III in acquired immunodeficiency syndrome.
Safai B; Sarngadharan MG; Groopman JE; Arnett K; Popovic M; Sliski A; Schüpbach J; Gallo RC
Lancet; 1984 Jun; 1(8392):1438-40. PubMed ID: 6145881
[TBL] [Abstract][Full Text] [Related]
2. IgG-antibodies to HTLV-III in patients with AIDS, LAS, and persons at risk of AIDS in West Germany.
Hehlmann R; Kreeb G; Erfle V; Piechowiak H; Krüger G; Goebel FD
Blut; 1985 Jan; 50(1):13-8. PubMed ID: 2981593
[TBL] [Abstract][Full Text] [Related]
3. Determinants of retrovirus (HTLV-III) antibody and immunodeficiency conditions in homosexual men.
Goedert JJ; Sarngadharan MG; Biggar RJ; Weiss SH; Winn DM; Grossman RJ; Greene MH; Bodner AJ; Mann DL; Strong DM
Lancet; 1984 Sep; 2(8405):711-6. PubMed ID: 6148471
[TBL] [Abstract][Full Text] [Related]
4. Prospective study of cytotoxic T lymphocyte responses to influenza and antibodies to human T lymphotropic virus-III in homosexual men. Selective loss of an influenza-specific, human leukocyte antigen-restricted cytotoxic T lymphocyte response in human T lymphotropic virus-III positive individuals with symptoms of acquired immunodeficiency syndrome and in a patient with acquired immunodeficiency syndrome.
Shearer GM; Salahuddin SZ; Markham PD; Joseph LJ; Payne SM; Kriebel P; Bernstein DC; Biddison WE; Sarngadharan MG; Gallo RC
J Clin Invest; 1985 Oct; 76(4):1699-704. PubMed ID: 2997287
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of antibody to human T-lymphotropic virus type III in AIDS and AIDS-risk patients in Britain.
Cheingsong-Popov R; Weiss RA; Dalgleish A; Tedder RS; Shanson DC; Jeffries DJ; Ferns RB; Briggs EM; Weller IV; Mitton S
Lancet; 1984 Sep; 2(8401):477-80. PubMed ID: 6147546
[TBL] [Abstract][Full Text] [Related]
6. Serum interferon and clinical manifestations of infection with human T-lymphotropic virus type III.
Abb J
Med Microbiol Immunol; 1985; 174(4):205-10. PubMed ID: 2999573
[TBL] [Abstract][Full Text] [Related]
7. IgM and IgG antibodies to human T cell lymphotropic retrovirus (HTLV-III) in lymphadenopathy syndrome and subjects at risk for AIDS in Italy.
Aiuti F; Rossi P; Sirianni MC; Carbonari M; Popovic M; Sarngadharan MG; Contu L; Moroni M; Romagnani S; Gallo RC
Br Med J (Clin Res Ed); 1985 Jul; 291(6489):165-6. PubMed ID: 2990634
[TBL] [Abstract][Full Text] [Related]
8. Relation of HTLV-III seropositivity and lymphadenopathy.
Jeffries E; Boyko WJ; Willoughby B; Constance PD; Wiggs B; O'Shaughnessy M; Sharp FR
Can Med Assoc J; 1985 Jul; 133(2):111-2. PubMed ID: 2988732
[TBL] [Abstract][Full Text] [Related]
9. Antibodies to human T lymphotropic virus type III demonstrated by a dot immunobinding assay.
Biberfeld G; Bredberg-Råden U; Böttiger B; Biberfeld P; Morfeldt-Månsson L; Suni J; Vaheri A; Saxinger C; Gallo R
Scand J Immunol; 1985 Mar; 21(3):289-92. PubMed ID: 2986278
[TBL] [Abstract][Full Text] [Related]
10. Seroepidemiology of human T-lymphotropic virus type III among homosexual men with the acquired immunodeficiency syndrome or generalized lymphadenopathy and among asymptomatic controls in Boston.
Groopman JE; Mayer KH; Sarngadharan MG; Ayotte D; Devico AL; Finberg R; Sliski AH; Allan JD; Gallo RC
Ann Intern Med; 1985 Mar; 102(3):334-7. PubMed ID: 2982305
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of AIDS-associated retrovirus and antibodies among male homosexuals at risk for AIDS in Greenwich Village.
Casareale D; Dewhurst S; Sonnabend J; Sinangil F; Purtilo DT; Volsky DJ
AIDS Res; 1984-1985; 1(6):407-21. PubMed ID: 6085926
[TBL] [Abstract][Full Text] [Related]
12. Antibodies reactive with human T-lymphotropic retroviruses (HTLV-III) in the serum of patients with AIDS.
Sarngadharan MG; Popovic M; Bruch L; Schüpbach J; Gallo RC
Science; 1984 May; 224(4648):506-8. PubMed ID: 6324345
[TBL] [Abstract][Full Text] [Related]
13. Low prevalence in the UK of HTLV-I and HTLV-II infection in subjects with AIDS, with extended lymphadenopathy, and at risk of AIDS.
Tedder RS; Shanson DC; Jeffries DJ; Cheingsong-Popov R; Clapham P; Dalgleish A; Nagy K; Weiss RA
Lancet; 1984 Jul; 2(8395):125-8. PubMed ID: 6146034
[TBL] [Abstract][Full Text] [Related]
14. Antibody to human T cell leukaemia virus type III in Australian homosexual men with lymphadenopathy.
Frazer IH; Sarngadharan MG; Mackay IR; Gallo RC
Med J Aust; 1984 Sep; 141(5):274-6. PubMed ID: 6088957
[TBL] [Abstract][Full Text] [Related]
15. Detection of IgG antibodies to lymphadenopathy-associated virus in patients with AIDS or lymphadenopathy syndrome.
Brun-Vezinet F; Rouzioux C; Barre-Sinoussi F; Klatzmann D; Saimot AG; Rozenbaum W; Christol D; Gluckmann JC; Montagnier L; Chermann JC
Lancet; 1984 Jun; 1(8389):1253-6. PubMed ID: 6144973
[TBL] [Abstract][Full Text] [Related]
16. Immunological and virological investigation in patients with lymphoadenopathy syndrome and in a population at risk for acquired immunodeficiency syndrome (AIDS), with particular focus on the detection of antibodies to human T-lymphotropic retroviruses (HTLV III).
Sirianni MC; Rossi P; Scarpati B; Ragona G; Seminara R; Bonomo G; Aiuti F
J Clin Immunol; 1985 Jul; 5(4):261-8. PubMed ID: 2995433
[TBL] [Abstract][Full Text] [Related]
17. The relationship of abnormalities of cellular immunity to antibodies to HTLV-III in homosexual men.
Dobozin BS; Judson FN; Cohn DL; Penley KA; Rickmann PE; Blaser MJ; Sarin PS; Weiss SH; Kirkpatrick CH
Cell Immunol; 1986 Mar; 98(1):156-71. PubMed ID: 3017581
[TBL] [Abstract][Full Text] [Related]
18. Human T-lymphotropic retrovirus type III (HTLV-III) in Danish homosexuals.
Lange Wantzin G; Saxinger WC; Weismann K; Gallo RC
Acta Derm Venereol; 1985; 65(3):247-50. PubMed ID: 2411083
[TBL] [Abstract][Full Text] [Related]
19. Human T-cell lymphotropic virus type III associated disorders. The spectrum in the heterosexual population.
Gill PS; Levine AM; Meyer PR; Aguilar SL; Rarick M; Parker JW; Rasheed S
Arch Intern Med; 1986 Aug; 146(8):1501-4. PubMed ID: 3015064
[TBL] [Abstract][Full Text] [Related]
20. HTLV-I-specific antibody in AIDS patients and others at risk.
Robert-Guroff M; Blayney DW; Safai B; Lange M; Gelmann EP; Gutterman JW; Mansell PW; Goedert JL; Groopman JE; Steigbigel NH
Lancet; 1984 Jul; 2(8395):128-31. PubMed ID: 6146035
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
